- Research works
- 2 fractional, all time
- Citations
- 5 2.1 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Histiocytosis Association is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Histiocytosis Association publish most on?
By volume in 2022–2025: Histiocytic Disorders and Treatments, Tumors and Oncological Cases, Multiple Myeloma Research and Treatments and Sarcoma Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Histiocytic Disorders and Treatments Physiology 1 works
- 2 Tumors and Oncological Cases Pathology and Forensic Medicine 0 works
- 3 Multiple Myeloma Research and Treatments Hematology 0 works
- 4 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 5 Autoimmune and Inflammatory Disorders Research Hematology 0 works
- 6 Family Support in Illness Sociology and Political Science 0 works
- 7 Viral-associated cancers and disorders Oncology 0 works
- 8 Immunodeficiency and Autoimmune Disorders Immunology 0 works
- 9 Genetic and rare skin diseases. Genetics 0 works
- 10 Musculoskeletal synovial abnormalities and treatments Rheumatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Histiocytosis Association's research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Pitman
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.